Effect of exercise on ovarian morphology and expression of nerve growth factor and alpha(1)- and beta(2)-adrenergic receptors in rats with steroid-induced polycystic ovaries

J Neuroendocrinol. 2005 Dec;17(12):846-58. doi: 10.1111/j.1365-2826.2005.01378.x.

Abstract

Oestadiol valerate (EV)-induced polycystic ovaries (PCO) in rats cause anovulation and cystic ovarian morphology. Denervation of ovarian sympathetic nerves restores ovulatory disruption. In the present study, we determined whether 5 weeks of voluntary exercise influence ovarian morphology and the expression of sympathetic markers in the EV-induced PCO rat model. The effect of exercise on (i) ovarian morphology; (ii) mRNA and protein expression of nerve growth factor (NGF); and (iii) mRNA and number of ovarian-expressing cells for the NGF receptor (p75 neurotrophin receptor) and the alpha(1a)-, alpha(1b)-, alpha(1d)- and beta(2)-adrenergic receptors (ARs) in rats with EV-induced PCO was evaluated. PCO was induced by a single i.m. injection of EV, and controls were injected with oil alone in adult cycling rats. The rats were divided into four groups: (i) control (oil); (ii) exercise group (oil + exercise); (iii) a PCO group (EV); and (iv) a PCO exercise group (EV + exercise). The exercise and PCO exercise groups ran voluntarily for 5 weeks in computer-monitored wheels placed in the cages where they were housed. The results obtained indicated that ovarian morphology was almost normalised in the PCO exercise group; NGF mRNA and protein concentrations were normalised in the PCO exercise group; high numbers of NGF receptor expressing cells in PCO ovaries were lowered by exercise; and the number of immunopositive cells of the different AR subtypes were all reduced after exercise in the PCO group, except for the alpha(1b)- and beta(2)-AR whereas the mRNA levels were unaffected, indicating transcriptional regulation. In conclusion, our data indicate a beneficial effect of regular exercise, as a modulator of ovarian sympathetic innervation, in the prevention and treatment of human PCOS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Body Weight
  • Estradiol / analogs & derivatives
  • Female
  • Nerve Growth Factor / genetics*
  • Organ Size
  • Ovary / innervation
  • Ovary / pathology
  • Ovary / physiopathology
  • Physical Exertion / physiology*
  • Polycystic Ovary Syndrome / chemically induced
  • Polycystic Ovary Syndrome / pathology
  • Polycystic Ovary Syndrome / physiopathology*
  • RNA, Messenger / analysis
  • Rats
  • Rats, Inbred WKY
  • Receptor, Nerve Growth Factor / genetics
  • Receptors, Adrenergic, alpha-1 / genetics*
  • Receptors, Adrenergic, beta-2 / genetics*
  • Sympathetic Nervous System / physiology

Substances

  • RNA, Messenger
  • Receptor, Nerve Growth Factor
  • Receptors, Adrenergic, alpha-1
  • Receptors, Adrenergic, beta-2
  • Estradiol
  • Nerve Growth Factor